That investigation has now been completed, and a report from Watson Mangioni has been provided to,
and considered by, the Board. The contents of that report are privileged and confidential.
After due consideration, the Board of Sirtex has today terminated Mr Wong’s employment with Sirtex,
with immediate effect. Mr Wong’s salary and statutory entitlements will be paid to the date of
termination. All unvested performance rights previously issued to Mr Wong have been forfeited.
Mr Nigel Lange has been appointed as Acting CEO, effectively immediately. Mr Lange is the current
Chief Operating Officer of Sirtex, with over 14 years direct experience in the core SIR-Spheres ® Y-90
resin microspheres business.
Mr Lange commented “I look forward to delivering on our strategies, to maximise the potential of our
SIR-Spheres microspheres technology, and to reinstate value to our shareholders.”
Sirtex will be conducting a thorough executive search and recruitment process to fill the position of
CEO and intends to appoint an executive search firm to oversee this process and conduct a global
search.
Separately, Sirtex is pleased to announce the appointment of Anthony (Tony) Dixon as the incoming
Chief Executive Officer, EMEA with immediate effect.
Mr Lange noted that “Tony has been with Sirtex Medical Europe for nine years and has a strong track
record in oncology and the medical devices sector, having served as National Sales Manager UK,
Director of Marketing and more recently the Vice President of Marketing EMEA.”
He also stated that he expects the appointment of a Chief Executive Officer, APAC will be made prior
to the end of January.
- Forums
- ASX - By Stock
- SRX
- Ann: Investigation of Concerns around CEO Share Trading
Ann: Investigation of Concerns around CEO Share Trading, page-2
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $74.27M |
Open | High | Low | Value | Volume |
17.5¢ | 18.0¢ | 17.5¢ | $132.6K | 758.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 449688 | 17.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 955405 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 449688 | 0.175 |
5 | 1608822 | 0.170 |
1 | 18186 | 0.165 |
1 | 2577 | 0.097 |
1 | 4000 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 945405 | 26 |
0.185 | 38427 | 3 |
0.190 | 220025 | 8 |
0.195 | 20478 | 2 |
0.200 | 181416 | 6 |
Last trade - 15.47pm 30/08/2024 (20 minute delay) ? |
Featured News
SRX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online